bluebird bio Inc at Cowen Healthcare Conference (Virtual) Transcript
So good afternoon, everybody, and thank you once again for joining us for the 41st Annual Cowen Health Care Conference. I'm Yaron Werber from the biotech team, and it's a great pleasure to moderate the fireside chat with bluebird bio. We have Nick Leschly, Chief bluebird; Phil Gregory, Chief Scientific Officer; and Chip Baird, Chief Financial Officer. Gentlemen, thanks so much. I really appreciate you joining us, and it's really timely to get an update.
So Nick, do you want to maybe do the forward-looking statements and then we'll go into Q&A.
Yes. You bet. First, thanks for having us. I think it is very timely. So I think it will be a good discussion.
So good afternoon, everyone. Before I begin, I would like to remind you that part of our conversation today will be making forward-looking statements about an ongoing investigation in the 2 safety events on the HGB-206
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |